Sunday, April 14, 2024
HomeMedical TechnologyAI indicates prostate cancer

AI indicates prostate cancer

- Advertisement -

AI indicates that prostate cancer is many diseases

Scientists have discovered a new aggressive kind of prostate cancer with the aid of artificial intelligence, which might completely change how the illness is identified and treated going forward.

One in eight men may get prostate cancer at some point in their lives. Research supported by Cancer Research UK and published in Cell Genomics has identified two distinct subtypes of the disease known as evotypes.

An multinational team lead by the Universities of Oxford and Manchester achieved the finding by using artificial intelligence (AI) to uncover two distinct subtypes affecting the prostate using DNA data.

The researchers believe that their research might one day save thousands of lives and completely change the way that prostate cancer is identified and managed. In the end, it may offer individualized medicines based on a genetic test that is likewise provided by AI for each patient.

The groundbreaking study demonstrates the impact that a prostate cancer diagnosis can have on one’s physical, emotional, and mental health. It was carried out with additional funding from Prostate Cancer Research and involved scientists from the University of Oxford, the University of Manchester, the University of East Anglia, and the Institute of Cancer Research, London.

Lead researcher Dr. Dan said, Our research shows that prostate tumors evolve along multiple pathways, leading to two distinct disease types. Woodcock of the University of Oxford’s Nuffield Department of Surgical Sciences. This knowledge is crucial because it enables us to categorize tumors according to the manner in which the cancer develops, as opposed to only relying on specific gene alterations or expression patterns.

- Advertisement -

In order to analyze genetic data from hundreds of prostate cancer samples from nine different nations, scientists from The Institute of Cancer Research (ICR) and The University of East Anglia formed an international partnership known as The Pan Prostate Cancer Group, which brought the researchers together.

Most importantly, the team is working with Cancer Research UK (CRUK) to create a genetic test that can offer a more accurate prognosis for each patient, enabling customized treatment options, when paired with traditional staging and grading.

159 individuals’ prostate cancer samples were examined utilizing whole genome sequencing and artificial intelligence (AI).

Using an AI method known as neural networks, they separated these individuals into two groups based on different types of cancer. Two further mathematical techniques applied to separate parts of the data were used to corroborate these two categories. This result was confirmed in other independent Australian and Canadian datasets.

After combining all the data, they created an evolutionary tree that depicted the progression of the two prostate cancer subtypes and how they eventually came to be known as “evotypes,” two different disease forms.

According to Dr. Rupal, the work released today by this international group of experts has the potential to significantly impact those impacted by prostate cancer. Mistry, senior Science Engagement Manager at CRUK. The more our knowledge about cancer, the more likely it is that we will find a cure. We are honored to have contributed to the funding of this innovative research, which has set the stage for more individuals to successfully treat their prostate cancer by providing tailored therapies.

 

- Advertisement -
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular